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Abstract 
Objective  
We  examined the effect of hypoxemia on fetal heart rate variability using the instrumented 
fetal sheep model.  
Methods  
In this prospective study, 19 pregnant sheep were instrumented under general anesthesia at a 
mean gestational age of 127 days. After a 5-day recovery, hypoxaemia was induced by 
attaching the mother to a re-breathing circuit. Hypoxemia was further extended till 120 
minutes, following which it was reversed till matenal and fetal pO2 returned back to baseline.  
The heart rate recordings at baseline, hypoxemia of 30 and 120 minutes, and recovery were 
analysed to calculate short term variation (STV) in 16 epochs of 3.75sec each, every minute. 
Phase rectified signal averaging (window length L= 10, time T= 2 and Scale S=T) was used 
to calculate acceleration capacity (AC) and deceleration capacity (DC).  
Results  
At baseline, mean (SD) fetal pO2 was 2.90±0.38 kPa. Acute hypoxaemia was associated with 
a significant reduction in mean pO2 at 30 (1.60±0.37 kPa) and 120 (1.50±0.16 kPa) minutes.  
Mean (SD) fetal pO2 at recovery was 2.80±0.32 kPa. The median STV, AC and DC were 
1.307 msec (IQR: 0.515 to 2.508), 1.295 (IQR: 0.990 to 2.685) BPM and 1.197 (IQR: 0.850 
to 1.836) BPM respectively, at baseline. With 30-minute hypoxaemia, the values were 1.323 
(IQR 0.753 to 2.744) msecs, 1.696 (IQR: 1.310 to 3.013) BPM & 1.584 (IQR 1.217 to 4.132) 
BPM. With 120-minute hypoxaemia, the values were  1.760 (IQR: 0.928 – 4.656) msecs, 
3.098 (IQR: 1.530 – 5.163) BPM &  3.054 (IQR: 1.508 – 4.522) BPM. At recovery they 
changed to 0.962 (IQR: 0.703 – 1.154) msecs, 1.228 (IQR: 1.071 – 2.234) BPM & 1.086 
(IQR: 0.873 – 1.568) BPM respectively. Hypoxemia for 30 and 120 minutes were associated 
with a significant increase in the DC compared to baseline (p = 0.014 & 0.017 respectively). 
The changes in STV and AC were not significant. 
Conclusion  
Acute hypoxaemia is associated with a significant increase in the deceleration capacity of the 
fetal heart rate. 
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Introduction 
There are several tests available for antenatal assessment of fetal wellbeing, and the analysis 
of the fetal heart rate and rhythm is one of them. Fetal hypoxemia is reported to be associated 
with initial increase followed by a reduction in heart rate variability in fetuses of pregnant 
ewe subjected to placental embolisation1. On the other hand, in a pregnant sheep model 
where hypoxaemia was induced by repeated intermittent umbilical cord compression, Green 
et al2 reported that high variability episodes of the fetal heart are less commonly observed 
with fetal hypoxemia, and only after four days. A commercial system that uses a computer to 
analyse antenatal fetal heart tracing is available3, and is used clinically for decision making to 
decide the time of delivery in early onset fetal growth restriction4. This commercial system 
acquires fetal heart rate using a trans-abdominal Doppler transducer. Variation between the 
interval of successive heart beats (short term variation, STV) is calculated in 16 epochs of 
3.75 seconds each, every minute, and expressed as milliseconds3.  Phase-rectified signal 
averaging (PRSA), is a relatively new technique, which synchronizes the phase of all periodic 
components of a noisy, non-stationary signal irrespective of their frequencies or characteristic 
time scales. It has been used for computerized assessment of the fetal heart rate variability 
antenatally5-7 as well as intrapartum8.  
In this study, using an instrumented pregnant fetal sheep model, we explored the effect of 
acute hypoxemia induced by maternal hypo-oxygenation on the fetal heart rate and its 
variability. 
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Material and methods 
The study protocol was reviewed and approved by the National Animal Experiment Board of 
Finland (ESAVI/1007/04.10.07/2014). The animal care and experimental procedures were 
conducted according to the national legislation and the EU Directive 2010/63/EU.  
Intrumentation 
Data from 19 instrumented pregnant sheep were used for this report. Surgery was performed 
at 119–128 gestational days (term 145 days, 0.88 of term). The details of the surgical 
technique have been described before9. Ewes were fasted overnight and pre-medicated with 
intramuscular ketamine (2 mg/kg) and midazolam (0.2 mg/kg). The maternal external jugular 
vein was cannulated and Ringer’s lactate solution was infused at a rate of 200 ml/h. General 
anaesthesia was induced with intravenous Propofol (4–7 mg/kg) and maintained with 
Isoflurane (1.5–2.5%) in an oxygen–air mixture delivered via an endotracheal tube. 
Intravenous boluses of fentanyl (0.05–0.15 mg) were administered as required.  
A laparotomy was performed under general anesthesia and endotracheal intubation. The fetal 
head and neck were delivered through a small uterine incision. Catheters were introduced in 
the internal jugular vein and the carotid artery to allow access to arterial venous circulations 
and to collect blood samples. A catheter was anchored to the fetal skin to measure amniotic 
fluid pressure. After the replacement of amniotic fluid by 0.9% warm saline and closure of 
the surgical wounds, all catheters and probes were tunnelled subcutaneously and exteriorized 
through a small skin incision in the ewe’s flank. Postoperative analgesia was provided with a 
fentanyl patch 50 mg/h attached to the ewe’s tail, with additional intramuscular injections of 
fentanyl 1.5 to 2 mg/kg twice daily. Throughout the recovery period of 4-5 days, the ewes 
received daily intravenous infusions of one liter of Ringer’s lactate solution with Ampicillin 1 
g, and the fetuses were given intravenous injections of benzyl penicillin 1 000 000 IU. After a 
4-day recovery at 123–132 gestational days, general anaesthesia was induced again as 
described above. A 16-gauge polyurethane catheter was inserted into the maternal descending 
aorta through a femoral artery. Thereafter, the ewe was placed supine with a left lateral tilt 
and allowed to stabilize for 30 min before the baseline measurements. Thereafter, maternal 
hypoxemia was induced by replacing inhaled oxygen with medical air in the re-breathing 
circuit to further decrease fetal pO2. Maternal oxy-hemoglobin saturation was kept at the 
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level of 75–80% for 20 min before the data collection for the hypoxemia phase was started 
and was maintained at this level during the data collection. Hypoxaemia was continued and 
another set of data were collected at 120 minutes of hypoxaemia. Thereafter, maternal 
hypoxaemia was reversed and the last set of data were collected. At the end of the 
experiment, the animals were euthanized with an intravenous overdose (1.0 mg/kg) of 
pentobarbital sodium. Fetal weight was recorded. 
 
Fetal heart rate analysis  
Fetal blood pressure and amniotic fluid pressure were measused continuously using pressure 
transducers (model DT-XX, Ohmeda, Hatfield, UK) at a sampling rate of 100 Hz using a 
polygraph (model UIM100A, Biopac Systems, Santa Barbara, CA) and computerized data 
acquisition software (Acqknowledge version 4.0 for Windows, Biopac Systems). Fetal blood 
pressure was referenced to amniotic fluid pressure. Fetal heart rate (FHR) was obtained from 
the arterial pressure by measuring the peak to peak intervals in the pressure waveforms 
(Figure 1). Self-developed program in Matlab (2017b, Mathworks, Nattick, MA, USA). was 
used for all analyses of the traces. 
Disturbances in the traces at the times of collection of fetal blood samples were manually 
selected and excluded. The heart rate recordings at baseline and hypoxaemia were analysed 
to calculate short term variation (STV) in 16 epochs of 3.75 sec each, every minute after 
exclusion of accelerations and decelerations. The PRSA methods has been described in detail 
elsewhere6, 7, 10, 11. The PRSA algorithm for the time series of the FHR was created using 
Matlab (MATLAB 2018b, The MathWorks, Inc., MA). The first step was to filter the atrial 
pressure wave and de-trend the signal. Next step was to find peaks in the pressure wave-form 
to identify the RR intervals. Next step was to create epochs from the RR intervals in 3.75 
second segments. Then we identified acceleration and deceleration in the signal as anchor 
points. When all anchor points were identified by the algorithm, a window is selected 
surrounding each anchor point. All data from the windows are aligned at every anchor point 
in one common window. From this common window the acceleration part (AC) and 
deceleration part (DC) can be calculated. The calculation of AC and DC depend of three 
parameters: L, T and S and need to be specified. L is the length of the window surrounding 
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each anchor point. We have chosen L=50 in this study of the time series. T sets the low-pass 
filter value and is used when detecting the anchor points in the signal. The S value changes 
the settings of the oscillations when calculating the acceleration & deceleration capacity. In 
our study we used S=T. (Please see appendix for details of calculating STV, AC & DC).  
PRSA (Phase rectified signal averaging, window length L= 10, T= 2 and Scale S=T) was 
used to calculate average acceleration capacity (AC) and average deceleration capacity (DC). 
The animals in this experiment were under the effect of anaesthesia. Therefore, anaesthetics 
may play a role in modifying the fetal heart rate and its variability. In order to assess the 
effect of anaesthesia, we studied the heart rate and its variability of two animals before and 
after anaethetic was administered. 
Statistical analysis  
Normality of the data was checked using Kolmogorov –Smirnoff test. Paired ‘t’ test was used 
to compare diffrences between baseline and hypoxemia for normally distributed data. 
Wilcoxon signed rank test was used for the data with a non-normal distribution. SPSS v22 
was used for statistical analysis. p<0.05 was considered as statistically significant.  
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Results   
The mean gestational age, fetal weight and signal duration of the experimental animals are 
shown in Table 1. All 19 fetuses survived hypoxaemia for 30 minutes. Only 11 of the 19 
animals survived hypoxaemia for 120 minutes. Seven fetuses were alive till the end of the 
experiment. 
The results are summarised in Table 2. All the parameters except fetal serum lactate, STV, 
AC and DC were normally distributed. Mean (SD) Fetal pO2 was 2.90±0.38 kPa and median 
(IQR) lactate were 1.70 (1.57 to 2.95) mM/L respectively at baseline. Hypoxaemia was 
associated with a significant reduction in pO2 (1.62±0.37 kPa at 30 minutes and 1.51±0.16 
kPa at 120 minutes, p <0.001 for both). Fetal serum lactate levels were significantly higher at 
hypoxemia for 30 min, hypxaemia for 120 min and also at recovery (p = 0.002, p = 0.008 and 
p = 0.018 respectively, Related samples Wilcoxon signed rank test). Fetal pCO2 did not 
change significantly over the study period. Fetal pH was significantly lower (p = 0.013) at 
recovery stage as compared to baseline (Table 2). Fetal heart rate was significantly lower at 
recovery phase as compared to baaseline (p = 0.001, paired sample ‘t’ test).  
At baseline, the median STV, AC and DC were 1.307 msec (IQR: 0.515 to 2.508), 1.295 
(IQR: 0.990 to 2.685) BPM and 1.197 (IQR: 0.850 to 1.836) BPM respectively. Changes in 
STV, AC and DC with progressive hypoxaemia and recovery are seen in Table 2. Hypoxemia 
for 30 and 120 minutes were associated with a significant increase in the DC compared to 
baseline (p = 0.014 & 0.017 respectively). The changes in STV and AC were not statistically 
significant. 
The effect of anaesthesia was studied in two animals before and after anaethetic was 
administered. The results are shown in Table 3. Reduction was seen in baseline heart rate, 
STV, AC and DC with anaesthesia in each of the two animals studied. No statistical tests are 
possible to the limited number.  
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Discussion   
In this experiment, acute hypoxemia caused by maternal hypo-oxygenation was associated 
with significant an increase in fetal lactate, whereas the fetal pH remained relatively 
unchanged. The short-term variation as well as acceleration capacity did not change. 
Deceleration capacity showed a significant increase with acute hypoxaemia.  
Fetal heart rate vaiability has been used for fetal monitoring in compromised pregnancies4, 12. 
Fetal heart variability is thought to be under the control of sympathetic and parasympathetic 
systems, but the exact mechanism of control remains unclear13. Chemical sympathectomy led 
to a reduction in fetal heart rate variability as compared to controls, but  it did not alter 
increase in fetal heart rate variability in response to acute hypoxaemia resulting from 
umbilical cord occlusion14. Changes in sympathetic and parasympathetic influences on the 
heart rate are antagonistic in the fetus, but synergistic in the newborn15.  
Response to hypoxemia may vary depending on the cause and duration of hypoxemia16. 
Reduced STV has been reported in chronic hypoxemia caused by placental insufficiency4, 12, 
17. Increased variability has been reported in hypoxemic human fetuses during intrapartum 
fetal monitoring8, 18. 
Murotsuki et al1 reported on 1-hour short term variation of sheep fetuses in a group where the 
fetuses were exposed to hypoxia by placental embolization and compared it to fetuses with an 
intact placenta. The STV showed a significant increase within hours of hypoxia due to 
placental embolization. The mean 1-hour STV in the two groups of sheep fetuses were 6-9 
msecs and 9-11 msecs in the control and embolised group of sheep fetuses respectively. In 
our study the STV did not change significantly with hypoxemia. The method of inducing 
hypoxia (maternal hypoxemia using a re-breathing circuit) in our study was different from 
that reported by Murotsuki et al. Moreover, the mean STV values in the current study were 
significantly lower as compared to that reported by Murotsuki et al (embolisation of the 
abdominal aorta with microparticles). The gestational age of the fetuses in Muroksuki report 
(104-106 days) was lower as compared to the present one (127 days).  The fetal heart rate 
was recorded by electrodes placed on the fetal chest to obtain the ECG signal as opposed to 
arterial pressure waves in the current study. Animals in the Murotsuki report were not 
anaesthetised, whereas they were under the effect of general anaesthesia in order to perform 
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echocardiographic examinations in the present study. All these differences may explain why 
our results differ from that reported by Murotsuki at al.  The number of fetuses in the present 
study (n = 19) was more than that of Murotsuki (n = 12). Therefore, negative results are 
unlikely to have resulted from the study being underpowered.  
Similar findings in human fetuses have been reported by Georgieva et al8. They report their 
findings form the intrapartum cohort. PRSA DC was better than STV in the detection of 
fetuses with low cord pH. Intrapartum period is likely to be associated with acute hypoxemia, 
and their report supports the findings of current study, although they have not reported 
absolute PRSA DC values. Huhn et al11, reported on STV and AC in a cohort of growth 
restricted fetuses and compared the values to a cohort of normally grown fetuses. They 
reported that both STV and AC were both significantly lower in growth restricted fetuses, 
although there was no significant difference in the cord arteral pH of these newborns as 
compared to normal fetuses. Their results are contradictory to that from the current study, but 
the fetuses were exposed to chronic rather than acute hypoxia. The absolute values of AC in 
the growth restricted and normally grown fetuses were 1.97 bpm and 2.49 bpm respectively. 
These values are similar to the ones in the present report, although the Huhn´s study was 
carried out on un-anaesthetised human fetuses. Rivolta et al10 reported on the fetal heart rate 
AC and DC in response to mild, modereae and severe hypoxaemia caused by intermittent 
umbilical occlusions. The AC and DC were increased progressively with increasing degree of 
hypoxaemia. The R-R interval was calculated from the fetal ECG signal in this  report.  The 
results of the current study are in keeping with the Rivolta study.  
Availability of fetal blood gas analysis, controlled level of hypoxemia and continuous access 
to fetal circulation are strengths of our study. The level of hypoxemia could be standardised 
and measured, which is not possible in human observational studies. Repeated fetal blood gas 
analyses and their correlation with fetal pO2 is difficult in human setting. We utilised 
algorithm very similar to the one available in the commercial system (Oxford 8000 system) 
for consistency.  
The main weakness is that the animals were under the influence of anaesthetic agents. This 
may have had an influence on the fetal heart rate variability. The study protocol involved 
examination of the fetal echocardiography with ultrasound, which is not possible in operated 
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pregnant ewes without anaesthesia. We studied the effect of anaesthetic on two animals by 
collecting the heart rate data on awake and anaethetised animals. Although the number is 
limited, the effect is of anaesthetic administration was a reduction in STV, AC and DC in 
each of the two animals. Each fetus was used as its own control, ensuring similar effects of 
the anaesthetic agents at baseline and with hypoxia. Had there been no difference found 
between normoxic and hypoxic phases, the negative finding could have been attributable to 
the effect of anaesthesia. However, a significantly increased DC was seen even in 
anaesthetised animals in this study. The results of this study are valid for these experimental 
conditions. It cannot be concluded that, at other degree of hypoxemia the short time 
variability of the fetal heart rate will not change. 
Access to fetal circulation is not possible without instrumentation, which required surgery 
prior to the experiment. The surgical procedures may constitute a significant stress on the 
sheep fetuses, and it may be argued that the conditions are quite different from human fetuses 
exposed to hypoxaemia. Normal arterial blood gas values at the baseline phase suggest 
conditions close to physiologic circulatory state19. The study was carried out in a narrow 
gestational age window of 123-132 days, and may limit the validity and significance outside 
this time period.  Extrapolation of these results to human pregnancy should be done 
cautiously. However, the sheep model has been extensively used for research in fetal 
hemodynamics.  
In conclusion, acute hypoxaemia is associated with a significant increase in the deceleration 
capacity of the fetal heart rate in the instrumented fetal sheep model. This information will be 
applicable to detection of fetal compromise with acute hypoxia.  
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Figure legend 
 
Figure 1. Data capture on the polygraph. The top panel shows arterial pulses from the 
fetal carotid artery.  
Foot note: Peak to peak pulse interval was measured in successive peaks, and averaged over 
3.75 sec epochs assess fetal heart rate variability.  
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Table 1. Baseline characteristics of the study participants 
 
Parameter Mean/Median SD/IQR 
Gestational age in days 127 2.9 
Fetal weight in grams 2466 301 
Total duration of signal (minutes) 67.7 55.4 to 80.4 
Duration of signal loss (minutes) 4.9 4.4 to 12.8 
 
SD = Standard deviation, IQR = Interquantile range 
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Table 2. Fetal blood gases and Fetal heart rate parameters 
 
Parameter Baseline 
n = 19 
Hypoxaemia  
(30 min)  
n = 19 
Hypoxemia  
(120 min)  
n = 11 
Recovery  
n = 7 
Fetal heart rate (BPM) 174±28 171±30 163±34 141±30 
Fetal pO2 (kPa) 2.90±0.38 1.62±0.37# 1.51±0.16# 2.86±0.32 
Fetal pCO2 (kPa) 6.93±1.12 6.81±0.83 6.86±1.03 6.77±0.50 
Fetal pH 7.294 ±0.060 7.295±0.044 7.236±0.250 7.193±0.060 
Fetal base excess 
(mM/ml) 
-1.33±3.34 -1.71±3.46 -10.33±6.59 -9.14±3.93 
Fetal lactate (mM/ml) 1.70 
(1.57 to 2.95) 
3.20 
(2.41 to 4.97) 
9.23  
(5.14 – 13.81) 
9.25 
(4.70 – 14.0) 
STV (msec) 1.307  
(0.515 to 
2.508) 
1.323  
(0.753 to 
2.744) 
1.760  
(0.928 – 4.656 
0.962  
(0.703 – 1.154 
Acceleration Capacity 
(BPM) 
1.295  
(0.990 to 
2.685) 
1.696  
(1.310 to 
3.013) 
3.098  
(1.530 – 
5.163) 
1.228  
(1.071 – 
2.234) 
Deceleration Capacity 
(BPM) 
1.197  
(0.850 to 
1.836) 
1.584*  
(1.217 to 
4.132) 
3.054*  
(1.508 – 
4.522) 
1.086  
(0.873 – 
1.568) 
 
*Statistically significat compared to baseline (Wilcoxon Signed Ranks Test).  # p<0.001 
(paired sample ‘t’ test).  
STV: Baseline against Hypoxaemia (30 min): p = 0.314; Baseline against Hypoxaemia (120 
min): p = 0.285; Baseline against Recovery: p = 0.735. 
Acceleration capacity: Baseline against Hypoxaemia (30 min): p = 0.335; Baseline against 
Hypoxaemia (120 min): p = 0.139;  Baseline against Recovery: p = 0.310 
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Deceleration capacity: Baseline against Hypoxaemia (30 min): p = 0.014; Baseline against 
Hypoxaemia (120 min): p = 0.017;  Baseline against Recovery: p = 1.00 
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Table 3. The effect of anaesthesia on fetal heart rate and its variability assessed by 
computerised CTG.  
Parameter Animal no. Awake Anaesthetised 
Fetal heart rate (BPM) 
1 146 131 
2 169 119 
STV (msec) 
1 6.24 2.73 
2 3.63 2.87 
Acceleration Capacity (BPM) 
1 5.68 1.47 
2 4.87 2.41 
Deceleration Capacity (BPM) 
1 6.08 1.48 
2 4.01 2.43 
 
No statistical tests have been performed due to the limited number of animals.  
BPM = beats per minute, STV = Short-term variation, msec = milliseconds 
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